Oncolytic Virus Immunotherapy Market Scope And Analysis

  • Report Code : TIPRE00016666
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Analisi dell'ambito di mercato dell'immunoterapia con virus oncolitico e concorrenti entro il 2025-2031

Buy Now

Oncolytic Virus Immunotherapy Market Report Oncolytic Virus Immunotherapy Market Size and Share Oncolytic Virus Immunotherapy Market Scope and Analysis

Oncolytic Virus Immunotherapy Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Tipo di virus
  • virus dell'Herpes Simplex
  • virus del vaccino
  • adenovirus
  • reovirus
  • altri
By Via di somministrazione
  • intratumorale
  • endovenosa
By Applicazione
  • melanoma
  • cancro polmonare non a piccole cellule
By Geografia
  • America del Nord
  • Europa
  • Asia-Pacifico
  • America centrale e meridionale
Regions and Countries Covered Nord America
  • Stati Uniti
  • Canada
  • Messico
Europa
  • Regno Unito
  • Germania
  • Francia
  • Russia
  • Italia
  • Resto Europa
Asia-Pacifico
  • Cina
  • India
  • Giappone
  • Australia
  • resto delAsia-Pacifico
America centrale e meridionale
  • Brasile
  • Argentina
  • Resto delAmerica Centrale e Meridionale
Medio Oriente e Africa
  • Sudafrica
  • Arabia Saudita
  • Emirati Arabi Uniti
  • Resto del Medio Oriente e Africa
Market leaders and key company profiles
  • Amgen, Inc.
  • Merck KGaA
  • Shanghai Sunway Biotech Co. Ltd.
  • TILT Biotherapeutics
  • Oncorus, Inc.
  • Oncolys BioPharma, Inc.
  • Sorrento Therapeutics, Inc.
  • Oncolytics Biotech, Inc.
  • SillaJen, Inc.